Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to establish reference values for thromboelastography (TEM-A) in healthy pregnant women during labor and 2 hours and 24 hours after delivery.


Clinical Trial Description

Previous, preliminary investigations by using thromboelastography, confirmed that pregnancy is a hypercoaguable state which remains in the first 24 hours postdelivery. Unfortunately results obtained by the existing studies that attempted to establish reference values for TEG suffer considerable bias.

The aim of this study will be to determine the range values for thomboelastography in pregnant women. Since there is no available information on the expected distribution of the outcome, a sequential design will be used. The main endpoint of the analysis will be a reliable estimate for the outcome expected in healthy women after labor. The investigators will state their target estimate as being reliable when the ratio between the estimate and its standard error is smaller than 2.

During labor, 2 hours after delivery and 24 hours postpartum, a venous blood sample will be taken from eligible women for thromboelastographic determination. Whole blood nonadditive TEM will be performed on the TEM-A automated thromboelastometer (Framar Biomedica,Rome, Italy) to obtain the four classical TEM parameters: reaction (R) time, k time, alpha angle and maximum amplitude (MA).

Inclusion criteria Healthy parturients in labor Exclusion criteria parturients who will eventually had: operative or instrumental vaginal delivery, estimated blood loss greater than 500 mL, the occurrence of II and III degree perineal lacerations, any coagulation disorder or anticoagulant therapy ;


Study Design

Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01506102
Study type Interventional
Source Città di Roma Hospital
Contact Giorgio Capogna, MD
Phone 0039065847
Email capogna.giorgio@gmail.com
Status Recruiting
Phase N/A
Start date November 2011
Completion date May 2012

See also
  Status Clinical Trial Phase
Completed NCT01765881 - Comparison Between 25 µg Vaginal Misoprostol vs Slow Release Pessary PGE2 Phase 2
Completed NCT02570620 - Contribution of Ultrasonography in the Evaluation of Cervical Induction-delivery Time N/A
Completed NCT02655783 - Use of Normal Saline With or Without Dextrose During Induction of Labor in Nulliparous N/A
Recruiting NCT01505192 - Noninvasive Continuous Measurement of SpHb After Spontaneous Vaginal Delivery N/A